España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Invivyd
IVVD
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.4439
0.01
3.30%
At close: -
$0.4301
-0.01
-3.11%
After Hours: Dec 20, 6:23 PM EDT
Get Report
Comment
Invivyd (IVVD) Forecast
News
Earnings
Invivyd (IVVD) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Invivyd (NASDAQ:IVVD) Stock
Invivyd Stock (NASDAQ: IVVD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 21, 2024
D. Boral Capital Maintains Buy on Invivyd, Ma...
Benzinga Newsdesk
Wednesday, November 20, 2024
Morgan Stanley Maintains Overweight on Invivy...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Invivyd,...
Benzinga Newsdesk
Thursday, November 14, 2024
D. Boral Capital Maintains Buy on Invivyd, Ma...
Benzinga Newsdesk
Invivyd Q3 2024 GAAP EPS $(0.51) Misses $(0.3...
Benzinga Newsdesk
Invivyd Announces That The New England Journa...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2024
Benzinga Insights
Wednesday, November 13, 2024
Earnings Outlook For Invivyd
Benzinga Insights
Tuesday, November 12, 2024
Invivyd Publishes CANOPY Phase 3 Trial Data P...
Benzinga Newsdesk
Wednesday, October 30, 2024
This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Wednesday
Avi Kapoor
EF Hutton Initiates Coverage On Invivyd with ...
Benzinga Newsdesk
Tuesday, October 29, 2024
HC Wainwright & Co. Reiterates Buy on Invivyd...
Benzinga Newsdesk
Invivyd shares are trading lower after the co...
Benzinga Newsdesk
Invivyd Reports Q3 2024 Preliminary Results W...
Benzinga Newsdesk
Invivyd's Phase 3 Results, PEMGARDA Demonstra...
Benzinga Newsdesk
Wednesday, October 16, 2024
Invivyd Announced The Upcoming Presentations ...
Benzinga Newsdesk
Tuesday, October 01, 2024
Invivyd's COVID Antibody PEMGARDA Retains Neu...
Benzinga Newsdesk
Monday, September 23, 2024
Invivyd Shares New Data on Pemivibart's Neutr...
Benzinga Newsdesk
Wednesday, September 04, 2024
Invivyd Announced Dosing Of The First Partici...
Benzinga Newsdesk
Tuesday, September 03, 2024
HC Wainwright & Co. Reiterates Buy on Invivyd...
Benzinga Newsdesk
Invivyd Reports Ongoing Neutralizing Effect O...
Benzinga Newsdesk
Friday, August 30, 2024
HC Wainwright & Co. Reiterates Buy on Invivyd...
Benzinga Newsdesk
Tuesday, August 27, 2024
HC Wainwright & Co. Reiterates Buy on Invivyd...
Benzinga Newsdesk
Invivyd shares are trading higher after the c...
Benzinga Newsdesk
Invivyd Announces 180-Day Exploratory Clinica...
Benzinga Newsdesk
Wednesday, August 21, 2024
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, August 14, 2024
Invivyd Expects To End 2024 With At Least $75...
Benzinga Newsdesk
Invivyd Q2 2024 GAAP EPS $(0.40) Misses $(0.3...
Benzinga Newsdesk
Monday, July 01, 2024
Invivyd Joins Russell 2000 And Russell 3000 I...
Benzinga Newsdesk
Friday, June 14, 2024
Invivyd Says VYD222 (pemivibart), A Half-life...
Benzinga Newsdesk
Friday, May 31, 2024
Invivyd Appoints Timothy Lee As Chief Commerc...
Benzinga Newsdesk
Invivyd Discloses General Alignment With U.S....
Benzinga Newsdesk
Friday, May 24, 2024
HC Wainwright & Co. Reiterates Buy on Invivyd...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on Invivyd...
Benzinga Newsdesk
Tuesday, May 07, 2024
Invivyd To Pursue Rapid Immunobridging Pathwa...
Benzinga Newsdesk
Monday, April 15, 2024
Invivyd Receives Healthcare Common Procedure ...
Benzinga Newsdesk
Friday, April 12, 2024
Invivyd Reveals CEO Transition; Appoints Jere...
Benzinga Newsdesk
Friday, April 05, 2024
Invivyd shares are trading higher after the c...
Benzinga Newsdesk
Guggenheim Upgrades Invivyd to Buy, Announces...
Benzinga Newsdesk
Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
Avi Kapoor
Thursday, April 04, 2024
Invivyd Sees FY24 Initial PEMGARDA Net Produc...
Benzinga Newsdesk
Invivyd's PEMGARDA Commercially Available In ...
Benzinga Newsdesk
Thursday, March 28, 2024
Invivyd: Q4 Earnings Insights
Benzinga Insights
Invivyd FY23 EPS $(1.81) Vs $(2.23) YoY
Benzinga Newsdesk
Tuesday, March 26, 2024
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Invivyd shares are trading higher after Morga...
Benzinga Newsdesk
Morgan Stanley Upgrades Invivyd to Overweight...
Benzinga Newsdesk
Monday, March 25, 2024
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch